|
WO2017198685A1
|
|
Method for determining sensitivity to a cdk4/6 inhibitor
|
|
WO2017182605A1
|
|
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
|
WO2016139335A1
|
|
Method for determining the degree of phosphorylation and the degree of glycosylation of a protein in a protein sample
|
|
EP3202491A1
|
|
Anti-bubble generator
|
|
US2018011011A1
|
|
Spectrometric ionic impurity measuring apparatus and method
|
|
EP3173752A1
|
|
Transducer with stiffness adjustment
|
|
WO2016050912A1
|
|
Hygroscopic salt apparatus
|
|
EP3135194A1
|
|
Improvements in or relating to heart monitoring
|
|
WO2015169857A1
|
|
Breast cancer epigenetic markers useful in anthracycline treatment prognosis
|
|
WO2015162158A1
|
|
Human motion tracking
|
|
WO2015150472A2
|
|
New strategies for treating melanoma
|
|
EP3037124A1
|
|
Drug delivery device with microneedles
|
|
WO2015055796A1
|
|
Formulations useful in the treatment of proliferative diseases affecting the respiratory tract
|
|
EP2892918A2
|
|
Immobilised cyclin-dependent kinase 4 fusion proteins and uses thereof
|
|
EP2738557A1
|
|
Organized immune response in cancer
|
|
EP2357539A1
|
|
Off-axis interferometer
|
|
EP2247717A2
|
|
Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
|
EP1989295A1
|
|
A method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof
|
